Skip to main content
OpenTrials

Clinical trial condition

Blood Coagulation Disorders, Inherited

Explore clinical trials studying Blood Coagulation Disorders, Inherited. Study availability and eligibility vary by location and protocol.

852 public trials 115 recruiting studies
Refine in advanced search Browse all conditions

Blood Coagulation Disorders, Inherited trial results

Completed

A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients

NCT02035605

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Clinical Trial Site Pittsburgh, Pennsylvania, United States
  • Clinical Trial Site Plovdiv, Bulgaria
  • Clinical Trial Site Sofia, Bulgaria
  • Clinical Trial Site Varna, Bulgaria
View all 14 locations
View Trial Details
Completed

Study of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Subjects With Severe Hemophilia A

NCT01027377

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Sacramento, California, United States
  • Research Site Waltham, Massachusetts, United States
  • Research Site Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Pharmacokinetics of rFVIIIFc at Two Vial Strengths

NCT02083965

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Salt Lake City, Utah, United States
  • Research Site Seattle, Washington, United States
  • Research Site Herston, Australia
View Trial Details
Completed

Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B

NCT01425723

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Sacramento, California, United States
  • Research Site Aurora, Colorado, United States
  • Research Site Atlanta, Georgia, United States
View all 49 locations
View Trial Details
Completed

Study of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in Previously Treated Pediatric Participants With Hemophilia B

NCT01440946

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Sacramento, California, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Honolulu, Hawaii, United States
View all 15 locations
View Trial Details
Completed

Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia A

NCT01458106

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Sacramento, California, United States
  • Research Site San Diego, California, United States
  • Research Site Aurora, Colorado, United States
View all 23 locations
View Trial Details
Completed

Phase I/IIa Study of FIXFc in Hemophilia B Patients

NCT00716716

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • RUSH University Medical Center Chicago, Illinois, United States
  • Indiana Hemophilia & Thrombosis Center Indianapolis, Indiana, United States
  • Brigham & Women's Hospital Boston, Massachusetts, United States
  • University of North Carolina Medical School Chapel Hill, North Carolina, United States
View Trial Details
Completed

Pharmacokinetics and Safety of rFVIIIFc Manufactured at 15,000 L (15K) Scale

NCT02502149

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Indianapolis, Indiana, United States
  • Research Site Louisville, Kentucky, United States
View all 15 locations
View Trial Details
Completed

Long-Term Safety and Efficacy of rFVIIIFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia A

NCT01454739

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Orange, California, United States
  • Research Site Sacramento, California, United States
View all 78 locations
View Trial Details
Completed

Study of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Participants With Hemophilia B

NCT01027364

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Sacramento, California, United States
  • Research Site Aurora, Colorado, United States
  • Research Site Chicago, Illinois, United States
View all 51 locations
View Trial Details

Related conditions